Bensler’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$401K Buy
1,581
+46
+3% +$10.7K 0.04% 147
2026
Q1
$375K Buy
1,535
+92
+6% +$21.4K 0.04% 136
2025
Q4
$299K Buy
1,443
+3
+0.2% +$593 0.03% 146
2025
Q3
$267K Sell
1,440
-126
-8% -$21.6K 0.03% 148
2025
Q2
$239K Sell
1,566
-252
-14% -$38.7K 0.03% 154
2025
Q1
$301K Sell
1,818
-167
-8% -$26.1K 0.04% 126
2024
Q4
$287K Buy
1,985
+109
+6% +$16.9K 0.03% 133
2024
Q3
$304K Buy
1,876
+137
+8% +$21.8K 0.04% 127
2024
Q2
$254K Buy
1,739
+201
+13% +$29.9K 0.03% 137
2024
Q1
$243K Sell
1,538
-297
-16% -$47.3K 0.04% 138
2023
Q4
$288K Sell
1,835
-224
-11% -$34.3K 0.05% 129
2023
Q3
$321K Sell
2,059
-8
-0.4% -$1.32K 0.06% 118
2023
Q2
$342K Sell
2,067
-304
-13% -$49.1K 0.07% 117
2023
Q1
$368K Buy
2,371
+21
+0.9% +$3.39K 0.07% 114
2022
Q4
$415K Sell
2,350
-71
-3% -$12.3K 0.09% 111
2022
Q3
$396K Sell
2,421
-51
-2% -$8.63K 0.09% 109
2022
Q2
$439K Sell
2,472
-97
-4% -$17.3K 0.1% 106
2022
Q1
$455K Buy
+2,569
New +$437K 0.1% 104

Other funds holding JNJ

Bensler's JNJ Position: Q2 2026 in Review

Bensler increased its Johnson & Johnson (JNJ) stake by 3% in Q2 2026, buying an estimated $10.7K and bringing the position to 1,581 shares worth $401K. The position accounts for 0.04% of the portfolio, ranked #147.

Bensler first reported a position in JNJ in Q1 2022 and has held it in 18 quarters since. The position peaked at $455K in Q1 2022. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Bensler held 1,581 shares of Johnson & Johnson worth $401K as of Q2 2026.
  • Bensler bought 46 Johnson & Johnson shares in Q2 2026, an estimated $10.7K.
  • Johnson & Johnson made up 0.04% of Bensler's portfolio in Q2 2026, its #147 holding.
  • Bensler first reported a position in Johnson & Johnson in Q1 2022 and has held it in 18 quarters since.
  • Bensler's Johnson & Johnson position peaked at $455K in Q1 2022.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Bensler's 13F filing for Q2 2026, filed 23 Jul 2026.